Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2023; 13(8): 158-166


Moringa oleifera leaf extract ameliorates early stages of diabetic nephropathy in streptozotocin-induced diabetic rats

Ruttiya Thongrung, Patchareewan Pannangpetch, Laddawan Senggunprai, Sakkarn Sangkhamanon, Kampeebhorn Boonloh, Panot Tangsucharit.




Abstract
Cited by 1 Articles

Diabetic nephropathy (DN) is a long-term complication of diabetes mellitus. The characteristic of early-stage DN is glomerular hyperfiltration that has been linked to renal fibrosis. In the present study, we investigated the effect of Moringa oleifera (M. oleifera) leaf extract on DN in streptozotocin (STZ)-induced diabetic nephropathy rats. Rats were injected with 50 mg/kg STZ to establish the DN model. Four weeks after receiving an injection of STZ, DN rats were administered distilled water, M. oleifera leaf extract (100 or 200 mg/kg body weight/day), dapagliflozin (1 mg/kg body weight/day) or combinations of these for a further 8 weeks. DN rats exhibited significantly increased blood glucose (504.00±28.41 mg/dL), proteinuria (192.85±41.23 mg/24 h), albuminuria (6.68±1.54 mg/24 h), BUN (47.14±5.18 mg/dL) and creatinine clearance (5.64±.35 ml/min) (p

Key words: Diabetic nephropathy, Moringa oleifera, Streptozotocin, Renal fibrosis, Renal hyperfiltration, Oxidative stress






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.